Novel Imaging Approaches for Predicting Arrhythmic Risk

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Determination of ventricular arrhythmic risk is crucial for guiding management of cardiac disease. Although for patients at increased risk an implantable cardioverter-defibrillator is recommended, it is widely acknowledged that current criteria for device use based predominantly on left ventricular ejection fraction are deficient. Genesis of ventricular arrhythmias involves a complex interaction of myocardial substrate abnormalities, precipitating triggers, and modulating factors. There are much data showing that by more directly assessing these factors, noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enhances arrhythmic risk stratification beyond ejection fraction and commonly used electrocardiographic and serum biomarkers. It is anticipated that further technological advancements studied in well-designed clinical trials will provide both more precise determination of risk and guide therapies to enhanced survival and patient well-being.

Original languageEnglish (US)
JournalCirculation: Cardiovascular Imaging
Volume8
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Implantable Defibrillators
Radionuclide Imaging
Stroke Volume
Echocardiography
Cardiac Arrhythmias
Heart Diseases
Magnetic Resonance Spectroscopy
Biomarkers
Clinical Trials
Equipment and Supplies
Survival
Serum
Therapeutics

Keywords

  • arrhythmias
  • cardiac
  • cardiac
  • death
  • defibrillators
  • echocardiography
  • implantable
  • magnetic resonance imaging
  • MIBG
  • radionuclide imaging
  • sudden

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Novel Imaging Approaches for Predicting Arrhythmic Risk. / Travin, Mark I.; Feng, Dali; Taub, Cynthia C.

In: Circulation: Cardiovascular Imaging, Vol. 8, No. 11, 01.11.2015.

Research output: Contribution to journalArticle

@article{67dea69ceb9048d6bb0670bb07f59abe,
title = "Novel Imaging Approaches for Predicting Arrhythmic Risk",
abstract = "Determination of ventricular arrhythmic risk is crucial for guiding management of cardiac disease. Although for patients at increased risk an implantable cardioverter-defibrillator is recommended, it is widely acknowledged that current criteria for device use based predominantly on left ventricular ejection fraction are deficient. Genesis of ventricular arrhythmias involves a complex interaction of myocardial substrate abnormalities, precipitating triggers, and modulating factors. There are much data showing that by more directly assessing these factors, noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enhances arrhythmic risk stratification beyond ejection fraction and commonly used electrocardiographic and serum biomarkers. It is anticipated that further technological advancements studied in well-designed clinical trials will provide both more precise determination of risk and guide therapies to enhanced survival and patient well-being.",
keywords = "arrhythmias, cardiac, cardiac, death, defibrillators, echocardiography, implantable, magnetic resonance imaging, MIBG, radionuclide imaging, sudden",
author = "Travin, {Mark I.} and Dali Feng and Taub, {Cynthia C.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1161/CIRCIMAGING.115.003019",
language = "English (US)",
volume = "8",
journal = "Circulation: Cardiovascular Imaging",
issn = "1941-9651",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Novel Imaging Approaches for Predicting Arrhythmic Risk

AU - Travin, Mark I.

AU - Feng, Dali

AU - Taub, Cynthia C.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Determination of ventricular arrhythmic risk is crucial for guiding management of cardiac disease. Although for patients at increased risk an implantable cardioverter-defibrillator is recommended, it is widely acknowledged that current criteria for device use based predominantly on left ventricular ejection fraction are deficient. Genesis of ventricular arrhythmias involves a complex interaction of myocardial substrate abnormalities, precipitating triggers, and modulating factors. There are much data showing that by more directly assessing these factors, noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enhances arrhythmic risk stratification beyond ejection fraction and commonly used electrocardiographic and serum biomarkers. It is anticipated that further technological advancements studied in well-designed clinical trials will provide both more precise determination of risk and guide therapies to enhanced survival and patient well-being.

AB - Determination of ventricular arrhythmic risk is crucial for guiding management of cardiac disease. Although for patients at increased risk an implantable cardioverter-defibrillator is recommended, it is widely acknowledged that current criteria for device use based predominantly on left ventricular ejection fraction are deficient. Genesis of ventricular arrhythmias involves a complex interaction of myocardial substrate abnormalities, precipitating triggers, and modulating factors. There are much data showing that by more directly assessing these factors, noninvasive imaging using echocardiography, radionuclide imaging, and cardiac magnetic resonance enhances arrhythmic risk stratification beyond ejection fraction and commonly used electrocardiographic and serum biomarkers. It is anticipated that further technological advancements studied in well-designed clinical trials will provide both more precise determination of risk and guide therapies to enhanced survival and patient well-being.

KW - arrhythmias

KW - cardiac

KW - cardiac

KW - death

KW - defibrillators

KW - echocardiography

KW - implantable

KW - magnetic resonance imaging

KW - MIBG

KW - radionuclide imaging

KW - sudden

UR - http://www.scopus.com/inward/record.url?scp=84947747754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947747754&partnerID=8YFLogxK

U2 - 10.1161/CIRCIMAGING.115.003019

DO - 10.1161/CIRCIMAGING.115.003019

M3 - Article

VL - 8

JO - Circulation: Cardiovascular Imaging

JF - Circulation: Cardiovascular Imaging

SN - 1941-9651

IS - 11

ER -